COMMUNIQUÉ DE PRESSE publié le 10/01/2024 à 19:00, il y a 2 années 2 mois EMQX Enterprise 5.4: Integrating OpenTelemetry, OCPP, and Confluent for IoT Excellence EMQ, a leading pioneer in open-source MQTT messaging with its platform EMQX, has released EMQX Enterprise 5.4.0, introducing OpenTelemetry for distributed tracing and logging, extending support for the Open Charge Point Protocol (OCPP), and seamless integration with Confluent for efficient data processing. The latest version brings enhancements for observability, secure EV charging infrastructure, real-time data processing, improved performance, and robust security, solidifying EMQX Enterprise as the top choice for scalable and secure messaging in enterprise IoT. EMQX Enterprise 5.4.0 OpenTelemetry OCPP Protocol Gateway Confluent Integration IoT Messaging Platform
COMMUNIQUÉ DE PRESSE publié le 04/01/2024 à 19:00, il y a 2 années 3 mois EMQ & The Mobility Data Space Community (MDS): Collaborating to Drive Sustainable Mobility Forward EMQ, the developer of the world's leading open-source MQTT messaging platform, EMQX, proudly announces its official membership in the Mobility Data Space (MDS) community. The MDS community integrates data and technology to enhance accessibility, safety, and efficiency in global transportation systems, aligning perfectly with EMQ's vision of fostering a more intelligent and interconnected mobile experience through cross-industry collaboration. EMQ MQTT Messaging Platform Mobility Data Space MDS Community Global Transportation Systems
COMMUNIQUÉ DE PRESSE publié le 28/12/2023 à 19:00, il y a 2 années 3 mois EMQ Joins the Connected Vehicle Trade Association (CVTA) EMQ Technologies, Inc. is pleased to announce its membership in the Connected Vehicle Trade Association (CVTA). As the world's leading software provider of open-source IoT data infrastructure, EMQ brings valuable expertise to the CVTA's resilient community. Their commitment to fostering new business opportunities aligns seamlessly with the collaborative spirit of CVTA. With their innovative solutions for vehicle data collection and integration, EMQ is poised to drive the future of IoT applications in the connected car technology space.
COMMUNIQUÉ DE PRESSE publié le 27/12/2023 à 19:00, il y a 2 années 3 mois LF Edge Embraces NanoMQ: A Testament to EMQ's IoT Innovation EMQ, the pioneer of the world's leading open-source MQTT messaging platform, EMQX, is excited to announce that NanoMQ has joined the LF Edge project portfolio. LF Edge is an umbrella organization within the Linux Foundation that focuses on creating an open and interoperable framework for edge computing. NanoMQ is an ultra-lightweight and high-performance Message Queuing Telemetry Transport (MQTT) broker optimized for IoT Edge. It plays a critical role in unifying data between Edge and Cloud, enabling
COMMUNIQUÉ DE PRESSE publié le 21/12/2023 à 19:00, il y a 2 années 3 mois AI-Enhanced MQTT Experience: EMQ's MQTTX 1.9.7 Unveils AI-Driven Copilot
COMMUNIQUÉ DE PRESSE publié le 20/12/2023 à 16:00, il y a 2 années 3 mois EMQ at Smart Cities Connect 2023: Driving Urban Transformation with Innovative IoT Data Solutions
COMMUNIQUÉ DE PRESSE publié le 13/12/2023 à 16:00, il y a 2 années 3 mois Transforming the Automotive Landscape: EMQ at Connected Vehicles Europe 2023
COMMUNIQUÉ DE PRESSE publié le 11/12/2023 à 16:00, il y a 2 années 3 mois EMQ Joins the Connect with Confluent Partner Program, Enhancing IoT Data Ecosystems in the Cloud
COMMUNIQUÉ DE PRESSE publié le 08/12/2023 à 15:00, il y a 2 années 3 mois EMQ Earns Frost & Sullivan's 2023 Global Enabling Technology Leadership Award for MQTT Platforms
COMMUNIQUÉ DE PRESSE publié le 03/11/2023 à 09:00, il y a 2 années 5 mois EMQX's Remarkable Debut at Japan IT Week Autumn 2023
Publié le 07/04/2026 à 18:00, il y a 3 heures 39 minutes LDC : Chiffre d’affaires du 4 ème trimestre 2025-2026. Solide croissance du chiffre d’affaires au 4ème trimestre 2025-2026 et révision à la hausse des objectifs.
Publié le 07/04/2026 à 17:57, il y a 3 heures 42 minutes Peugeot Invest publishes its 2025 Universal Registration Document
Publié le 07/04/2026 à 17:57, il y a 3 heures 42 minutes Mise à disposition du Document d’enregistrement universel 2025
Publié le 07/04/2026 à 17:45, il y a 3 heures 54 minutes ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Publié le 07/04/2026 à 17:45, il y a 3 heures 54 minutes ENGIE accélère le déploiement du stockage par batteries avec près de 400 MW de nouveaux projets en Europe
Publié le 07/04/2026 à 15:00, il y a 6 heures 39 minutes Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Publié le 07/04/2026 à 14:45, il y a 6 heures 54 minutes Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Publié le 07/04/2026 à 14:40, il y a 6 heures 59 minutes bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Publié le 07/04/2026 à 14:30, il y a 7 heures 9 minutes Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Publié le 07/04/2026 à 14:30, il y a 7 heures 9 minutes Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Publié le 07/04/2026 à 17:45, il y a 3 heures 54 minutes VAZIVA SA: Mise à jour des modalités de l’émission d’obligations convertibles en actions nouvelles (OCA) de 8 M€ à un taux de 7,0% par an et à maturité de 3 ans
Publié le 07/04/2026 à 17:45, il y a 3 heures 54 minutes FIGEAC AÉRO: INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 07/04/2026 à 17:40, il y a 3 heures 59 minutes VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Publié le 07/04/2026 à 16:32, il y a 5 heures 7 minutes Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.